Additionally, the 36-month beta value for NCNA is 1.59. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for NCNA is 5.33M and currently, short sellers hold a 11.26% ratio of that float. The average trading volume of NCNA on May 12, 2025 was 4.79M shares.
NCNA) stock’s latest price update
The stock price of NuCana plc ADR (NASDAQ: NCNA) has plunged by -59.18 when compared to previous closing price of 0.10, but the company has seen a -90.87% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-20 that Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025
NCNA’s Market Performance
NCNA’s stock has fallen by -90.87% in the past week, with a monthly drop of -94.40% and a quarterly drop of -95.71%. The volatility ratio for the week is 55.32% while the volatility levels for the last 30 days are 23.84% for NuCana plc ADR The simple moving average for the past 20 days is -93.27% for NCNA’s stock, with a -97.78% simple moving average for the past 200 days.
Analysts’ Opinion of NCNA
Truist gave a rating of “Buy” to NCNA, setting the target price at $22 in the report published on October 22nd of the previous year.
NCNA Trading at -94.50% from the 50-Day Moving Average
After a stumble in the market that brought NCNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.61% of loss for the given period.
Volatility was left at 23.84%, however, over the last 30 days, the volatility rate increased by 55.32%, as shares sank -94.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -95.48% lower at present.
During the last 5 trading sessions, NCNA fell by -90.87%, which changed the moving average for the period of 200-days by -98.90% in comparison to the 20-day moving average, which settled at $0.6244. In addition, NuCana plc ADR saw -96.47% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NCNA
The total capital return value is set at -3.73. Equity return is now at value -183.07, with -89.69 for asset returns.
Based on NuCana plc ADR (NCNA), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -100.62.
Currently, EBITDA for the company is -28.89 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.42.
Conclusion
In conclusion, NuCana plc ADR (NCNA) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
